Hinge Health (NYSE:HNGE) Director Kristina Leslie Sells 1,250 Shares

Hinge Health Inc. (NYSE:HNGE) Director Kristina Leslie sold 1,250 shares of the company’s stock in a transaction dated Friday, November 21st. The stock was sold at an average price of $45.68, for a total transaction of $57,100.00. Following the completion of the sale, the director directly owned 27,750 shares of the company’s stock, valued at approximately $1,267,620. This trade represents a 4.31% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.

Hinge Health Stock Performance

NYSE HNGE traded up $1.08 during trading on Monday, reaching $47.07. 1,715,754 shares of the company’s stock traded hands, compared to its average volume of 1,186,414. Hinge Health Inc. has a 12-month low of $33.42 and a 12-month high of $62.18. The company has a 50 day simple moving average of $49.69.

Hinge Health (NYSE:HNGE) last released its quarterly earnings data on Tuesday, November 4th. The company reported ($0.02) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.20) by $0.18. The business had revenue of $154.21 million for the quarter, compared to the consensus estimate of $142.44 million. The company’s revenue was up 53.3% compared to the same quarter last year. Hinge Health has set its FY 2025 guidance at EPS. Q4 2025 guidance at EPS.

Hinge Health announced that its Board of Directors has initiated a stock repurchase plan on Wednesday, November 12th that authorizes the company to buyback $250.00 million in outstanding shares. This buyback authorization authorizes the company to reacquire up to 7.2% of its shares through open market purchases. Shares buyback plans are often a sign that the company’s management believes its shares are undervalued.

Wall Street Analyst Weigh In

Several research firms have recently commented on HNGE. JMP Securities boosted their price target on Hinge Health from $58.00 to $65.00 and gave the stock a “market outperform” rating in a research report on Wednesday, August 6th. Needham & Company LLC lifted their target price on Hinge Health from $47.00 to $59.00 and gave the company a “buy” rating in a research note on Wednesday, August 6th. Canaccord Genuity Group boosted their target price on shares of Hinge Health from $61.00 to $65.00 and gave the stock a “buy” rating in a report on Wednesday, November 5th. Weiss Ratings restated a “sell (d)” rating on shares of Hinge Health in a report on Wednesday, October 8th. Finally, Evercore ISI lifted their price objective on shares of Hinge Health from $60.00 to $65.00 and gave the stock an “outperform” rating in a research report on Wednesday, October 8th. One analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $59.93.

Institutional Trading of Hinge Health

Institutional investors have recently bought and sold shares of the stock. Sandler Capital Management increased its stake in Hinge Health by 1.4% during the 3rd quarter. Sandler Capital Management now owns 52,728 shares of the company’s stock valued at $2,588,000 after purchasing an additional 728 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. acquired a new stake in shares of Hinge Health during the third quarter worth $37,000. Montag A & Associates Inc. purchased a new stake in shares of Hinge Health during the second quarter valued at $41,000. Jones Financial Companies Lllp grew its holdings in shares of Hinge Health by 348.0% during the third quarter. Jones Financial Companies Lllp now owns 1,120 shares of the company’s stock valued at $54,000 after buying an additional 870 shares during the last quarter. Finally, SBI Securities Co. Ltd. acquired a new position in shares of Hinge Health in the 2nd quarter valued at $48,000.

Hinge Health Company Profile

Our vision is to build a new health system that transforms outcomes, experience and costs by using technology to scale and automate the delivery of care. Hinge Health leverages software, including AI, to largely automate care for joint and muscle health, delivering an outstanding member experience, improved member outcomes, and cost reductions for our clients.